Corix Bioscience Stock Retained Earnings
| CXBS Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of Corix Bioscience allows traders to better anticipate movements in Corix Bioscience's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -11.2 M | -11.7 M |
Corix | Retained Earnings | Build AI portfolio with Corix Stock |
Corix Bioscience Company Retained Earnings Analysis
Corix Bioscience's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Corix Bioscience Retained Earnings | (12.42 M) |
Most of Corix Bioscience's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Corix Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Corix Bioscience has a Retained Earnings of (12.42 Million). This is 101.33% lower than that of the Healthcare sector and 122.89% lower than that of the Drug Manufacturers - Specialty & Generic industry. The retained earnings for all United States stocks is 100.13% higher than that of the company.
Corix Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Corix Bioscience's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Corix Bioscience could also be used in its relative valuation, which is a method of valuing Corix Bioscience by comparing valuation metrics of similar companies.Corix Bioscience is currently under evaluation in retained earnings category among its peers.
Corix Fundamentals
| Current Valuation | 820.28 K | ||||
| Shares Outstanding | 27.34 M | ||||
| Price To Book | 0.19 X | ||||
| Price To Sales | 0.43 X | ||||
| Revenue | 693.62 K | ||||
| EBITDA | (3.31 M) | ||||
| Net Income | (4.43 M) | ||||
| Cash And Equivalents | 360.87 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 5.08 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 0.16 X | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (1.85 M) | ||||
| Beta | -1.51 | ||||
| Market Capitalization | 820.28 K | ||||
| Total Asset | 11.37 M | ||||
| Retained Earnings | (12.42 M) | ||||
| Net Asset | 11.37 M |
About Corix Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corix Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corix Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corix Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corix Stock Analysis
When running Corix Bioscience's price analysis, check to measure Corix Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corix Bioscience is operating at the current time. Most of Corix Bioscience's value examination focuses on studying past and present price action to predict the probability of Corix Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corix Bioscience's price. Additionally, you may evaluate how the addition of Corix Bioscience to your portfolios can decrease your overall portfolio volatility.